DMKC Advisory Services LLC boosted its position in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 18.8% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 22,728 shares of the company’s stock after buying an additional 3,590 shares during the period. DMKC Advisory Services LLC’s holdings in Procter & Gamble were worth $3,333,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also recently added to or reduced their stakes in PG. Norges Bank bought a new stake in shares of Procter & Gamble in the fourth quarter valued at about $4,664,783,000. Cardano Risk Management B.V. raised its stake in Procter & Gamble by 1,104.8% in the 4th quarter. Cardano Risk Management B.V. now owns 9,521,440 shares of the company’s stock worth $1,364,518,000 after purchasing an additional 8,731,126 shares in the last quarter. Auto Owners Insurance Co raised its stake in Procter & Gamble by 14,231.0% in the 4th quarter. Auto Owners Insurance Co now owns 3,549,645 shares of the company’s stock worth $508,700,000 after purchasing an additional 3,524,876 shares in the last quarter. Vanguard Group Inc. grew its position in shares of Procter & Gamble by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 237,459,756 shares of the company’s stock worth $34,030,358,000 after purchasing an additional 2,829,151 shares in the last quarter. Finally, Amundi grew its position in shares of Procter & Gamble by 26.3% during the 3rd quarter. Amundi now owns 10,682,455 shares of the company’s stock worth $1,606,748,000 after purchasing an additional 2,222,560 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research firms have recently weighed in on PG. Barclays lifted their price target on shares of Procter & Gamble from $146.00 to $152.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 21st. JPMorgan Chase & Co. lowered their price objective on Procter & Gamble from $164.00 to $162.00 and set an “overweight” rating on the stock in a research note on Thursday, July 16th. Morgan Stanley cut their target price on Procter & Gamble from $175.00 to $166.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Bank of America reduced their target price on Procter & Gamble from $170.00 to $166.00 and set a “buy” rating on the stock in a report on Friday, July 10th. Finally, TD Cowen boosted their price target on Procter & Gamble from $142.00 to $150.00 and gave the company a “hold” rating in a research note on Monday, April 27th. Thirteen equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus target price of $161.52.
Procter & Gamble Stock Down 0.8%
NYSE PG opened at $146.79 on Thursday. The business has a fifty day moving average price of $147.80 and a two-hundred day moving average price of $148.99. The stock has a market capitalization of $341.81 billion, a PE ratio of 22.17, a PEG ratio of 4.55 and a beta of 0.39. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $167.25. The company has a debt-to-equity ratio of 0.42, a current ratio of 0.68 and a quick ratio of 0.47.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.02. Procter & Gamble had a return on equity of 31.25% and a net margin of 18.44%.The company had revenue of $21.20 billion for the quarter, compared to analyst estimates of $21.38 billion. During the same quarter last year, the company posted $1.48 EPS. The company’s revenue for the quarter was up 1.5% compared to the same quarter last year. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. Equities analysts expect that Procter & Gamble Company will post 6.99 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, August 17th. Shareholders of record on Friday, July 24th will be paid a dividend of $1.0885 per share. The ex-dividend date of this dividend is Friday, July 24th. This represents a $4.35 annualized dividend and a yield of 3.0%. Procter & Gamble’s payout ratio is presently 65.71%.
More Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: P&G agreed to acquire premium supplements company Thorne for $3.8 billion in cash. The transaction expands P&G’s health-care portfolio alongside brands such as Metamucil, Align and New Chapter, and gives the company greater exposure to premium wellness and younger consumers. The deal is expected to close later this year. P&G will acquire supplements brand Thorne
- Positive Sentiment: Management and Thorne’s owner described the acquisition as a way to build on Thorne’s science-backed brand and growth in wellness. Investors initially viewed the purchase as a strategic move to diversify P&G beyond traditional household and personal-care products. L Catterton announces sale of Thorne to P&G
- Neutral Sentiment: Trading activity in P&G call options increased, indicating heightened investor interest and potentially more bullish positioning around the acquisition. However, options activity alone does not establish a change in the company’s fundamentals. Traders purchase large volume of P&G call options
- Negative Sentiment: P&G’s latest quarterly results showed a mixed picture: earnings per share of $1.43 topped estimates by $0.02, but revenue of $21.2 billion missed the $21.38 billion consensus and rose only 1.5% year over year. The sales shortfall and ongoing input-cost pressure may be limiting enthusiasm for the stock. PG Q2 deep dive
- Negative Sentiment: The $3.8 billion cash purchase creates execution and valuation risk, including the challenge of integrating Thorne and generating sufficient growth from the premium supplement business. Investors may also be assessing the deal’s effect on P&G’s balance sheet and future returns.
Procter & Gamble Company Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Read More
- Five stocks we like better than Procter & Gamble
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
